content: <HTML>
  <HEAD>
       <TITLE></TITLE>
  </HEAD>
  <BODY STYLE="font: 10pt Times New Roman, Times, Serif">
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center"><B>As filed with the Securities and Exchange Commission
  on March 29, 2023</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: right"><B>Registration No. 333-</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: right"></P>
  
  <!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: right">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center"><B>UNITED STATES </B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center"><B>Washington, D.C. 20549 </B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center"><B>FORM S-8</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center"><B>REGISTRATION STATEMENT </B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center"><B><I>UNDER </I></B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center"><B><I>THE SECURITIES ACT OF 1933 </I></B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center"><B>BIOMX INC.</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center"><B>(Exact Name of Registrant as Specified in its
  Charter) </B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
    <TR>
      <TD STYLE="border-bottom: black 1.5pt solid; vertical-align: top; width: 32%; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Delaware</B></FONT></TD>
      <TD STYLE="vertical-align: bottom; width: 2%">&nbsp;</TD>
      <TD STYLE="border-bottom: black 1.5pt solid; vertical-align: top; width: 32%; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>2836</B></FONT></TD>
      <TD STYLE="vertical-align: bottom; width: 2%">&nbsp;</TD>
      <TD STYLE="border-bottom: black 1.5pt solid; vertical-align: top; width: 32%; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>82-3364020</B></FONT></TD></TR>
    <TR>
      <TD STYLE="vertical-align: top">
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center"><B>(State or other jurisdiction of</B></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center"><B>incorporation or organization)</B></P></TD>
      <TD STYLE="vertical-align: bottom">&nbsp;</TD>
      <TD STYLE="vertical-align: top">
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center"><B>(Primary Standard Industrial</B></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center"><B>Classification Code Number)</B></P></TD>
      <TD STYLE="vertical-align: bottom">&nbsp;</TD>
      <TD STYLE="vertical-align: top">
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center"><B>(I.R.S. Employer</B></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center"><B>Identification No.)</B></P></TD></TR>
    </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center"><B>22 Einstein St., Floor 4</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center"><B>Ness Ziona, Israel</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center"><B>+972 723942377</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center"><B>(Address, including zip code, and telephone
  number, including area code, of Registrant&rsquo;s principal executive offices) </B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center"><B>CHARDAN HEALTHCARE ACQUISITION CORP. 2019 OMNIBUS
  LONG-TERM INCENTIVE PLAN</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center"><B>(Full title of the plans) </B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center"><B>Marina Wolfson</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center"><B>BiomX Inc.</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center"><B>22 Einstein St., Floor 4</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center"><B>Ness Ziona, Israel</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center"><B>+972 723942377</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center"><B>(Name, address, including zip code, and telephone
  number, including area code, of agent for service) </B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center"><B><I>Copies to: </I></B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center"><B>Howard E. Berkenblit</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center"><B>Sullivan &amp; Worcester LLP</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center"><B>One Post Office Square</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center"><B>Boston, Massachusetts 02109</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center"><B>(617) 338-2800</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0">Indicate by check mark whether the registrant is a large accelerated
  filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of &ldquo;large accelerated
  filer,&rdquo; &ldquo;accelerated filer&rdquo; and &ldquo;smaller reporting company&rdquo; in Rule 12b-2 of the Exchange Act.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
    <TR STYLE="vertical-align: top">
      <TD STYLE="width: 20%; font-size: 10pt"><FONT STYLE="font-size: 10pt">Large accelerated filer</FONT></TD>
      <TD STYLE="width: 10%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
      <TD STYLE="width: 35%">&nbsp;</TD>
      <TD STYLE="width: 25%; font-size: 10pt"><FONT STYLE="font-size: 10pt">Accelerated filer</FONT></TD>
      <TD STYLE="width: 10%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD></TR>
    <TR STYLE="vertical-align: top">
      <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Non-accelerated filer</FONT></TD>
      <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD>
      <TD>&nbsp;</TD>
      <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Smaller reporting company</FONT></TD>
      <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD></TR>
    <TR STYLE="vertical-align: top">
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Emerging growth company</FONT></TD>
      <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD></TR>
    </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0">If an emerging growth company, indicate by check mark if the registrant
  has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
  to Section 7(a)(2)(B) of the Securities Act. <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9746;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0"><B>&nbsp;</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0"><B></B></P>
  
  <!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0"><B>&nbsp;</B></P>
  
  
  <!-- Field: Page; Sequence: 1 -->
      <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
      <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0"><B>&nbsp;</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center"><B>EXPLANATORY NOTE</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0">On January 2, 2020, BiomX Inc., or the Company, filed a Registration
  Statement on Form S-8 (File No. 333-235777), or, as amended, the Original Registration Statement, with the Securities and Exchange Commission,
  or the Commission, to register an aggregate of 1,000 shares of Common Stock of the Company that may be issued pursuant to the Chardan
  Healthcare Acquisition Corp. 2019 Omnibus Long-Term Incentive Plan, or the 2019 Plan, as well as 3,148,360 shares of Common Stock of the
  Company that may be issued pursuant to the 2015 Employee Stock Option Plan for Key Employees of BiomX Ltd., as amended.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0">Pursuant to the 2019 Plan, the number of shares of Common Stock of
  the Company made available under the 2019 Plan will automatically increase on January 1 of each year, for a period of not more than ten
  years, commencing on January 1, 2020 and ending on (and including) January 1, 2029, in an amount equal to 4% of the total number of shares
  of Common Stock outstanding on December 31 of the preceding calendar year, or the Evergreen Mechanism.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0">In accordance with the Evergreen Mechanism, the number of shares of
  Common Stock of the Company reserved under the 2019 Plan increased by 914,741, 930,813 and 1,190,129 shares of Common Stock effective
  January 1, 2020, January 1, 2021 and January 1, 2022, respectively. Further, in accordance with the Evergreen Mechanism, the number of
  shares of Common Stock of the Company reserved under the 2019 Plan increased by 1,199,291 shares of Common Stock effective January 1,
  2023.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0">The Company is filing this Registration Statement on Form S-8 to register
  an additional 1,199,291 shares of Common Stock of the Company, which may be issued in connection with securities awards, which have been
  granted or may hereafter be granted under the 2019 Plan. The 1,199,291 shares of Common Stock of the Company being registered hereunder
  for the 2019 Plan are comprised of: (i) 675,567 shares of Common Stock subject to awards granted on March 1, 2023; and (ii) 523,724 shares
  of Common Stock available for issuance.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0">Pursuant to General Instruction E to Form S-8, the contents of the
  Original Registration Statement are incorporated herein by reference, except for Item 3 and Item 8 of Part II of the Original Registration
  Statement, which are being updated by this Registration Statement.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0"><B>&nbsp;</B></P>
  
  
  <!-- Field: Page; Sequence: 2 -->
      <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
      <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0"><B>&nbsp;</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center"><B>PART II </B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center"><B>INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
  </B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0"><B>Item 3. Incorporation of Documents by Reference. </B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0">The following documents filed with the Securities and Exchange Commission,
  or the Commission, by BiomX Inc., or the Registrant, pursuant to the Securities Act of 1933, as amended, and the Securities Exchange Act
  of 1934, as amended, or the Exchange Act, are hereby incorporated by reference in this Registration Statement:</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
    <TR STYLE="vertical-align: top">
      <TD STYLE="width: 25px">&nbsp;</TD>
      <TD STYLE="width: 25px; font-size: 10pt"><FONT STYLE="font-size: 10pt">(a)</FONT></TD>
      <TD STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-size: 10pt">The Registrant&rsquo;s Annual Report on </FONT><FONT STYLE="font-size: 10pt"><A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/0001739174/000121390023024122/f10k2022_biomxinc.htm">Form 10-K</A></FONT> <FONT STYLE="font-size: 10pt">for the year ended December 31, 2022, filed with the Commission on March 29, 2023; </FONT></TD></TR>
    </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
    <TR STYLE="vertical-align: top">
      <TD STYLE="width: 25px">&nbsp;</TD>
      <TD STYLE="width: 25px; font-size: 10pt"><FONT STYLE="font-size: 10pt">(b)</FONT></TD>
      <TD STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-size: 10pt">The Registrant&rsquo;s Current Reports on Form 8-K filed
      on <A HREF="https://www.sec.gov/Archives/edgar/data/1739174/000121390023001398/ea171346-8k_biomx.htm" STYLE="-sec-extract: exhibit">January
      6, 2023</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/1739174/000121390023013615/ea174091-8k_biomxinc.htm" STYLE="-sec-extract: exhibit">February 22, 2023</A> (Items 1.01, 3.02, 8.01 and exhibits 4.1, 10.1 and 10.2 only), <A HREF="https://www.sec.gov/Archives/edgar/data/1739174/000121390023014891/ea174316-8k_biomxinc.htm" STYLE="-sec-extract: exhibit">February 27, 2023</A>, and <A HREF="https://www.sec.gov/Archives/edgar/data/1739174/000121390023023846/ea175977-8k_biomx.htm" STYLE="-sec-extract: exhibit">March 29, 2023</A>
      (Item 5.08 only); and</FONT></TD></TR>
    </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
    <TR STYLE="vertical-align: top">
      <TD STYLE="width: 25px">&nbsp;</TD>
      <TD STYLE="width: 25px; font-size: 10pt"><FONT STYLE="font-size: 10pt">(c)</FONT></TD>
      <TD STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-size: 10pt">The description of our common stock, warrants and units contained in the Registration Statement on </FONT><FONT STYLE="font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1739174/000161577418014343/s114652_8a12b.htm" STYLE="-sec-extract: exhibit">Form 8-A</A></FONT> <FONT STYLE="font-size: 10pt">filed on December 13, 2018, under the Exchange Act, including any amendment or report filed or to be filed for the purpose of updating such description.</FONT></TD></TR>
    </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0">All documents that the Registrant subsequently files pursuant to Sections
  13(a), 13(c), 14 and 15(d) of the Exchange Act after the date of this Registration Statement and prior to the filing of a post-effective
  amendment to this Registration Statement indicating that all securities offered have been sold or which deregisters all securities then
  remaining unsold, shall be deemed to be incorporated by reference into this Registration Statement and to be a part hereof from the date
  of filing of such documents; provided, however, that documents or information deemed to have been furnished and not filed shall not be
  incorporated by reference into this Registration Statement.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0">Any statement contained in a document incorporated or deemed to be
  incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent
  that a statement contained herein or in any other subsequently filed document which also is or is deemed to be incorporated by reference
  herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified
  or superseded, to constitute a part of this Registration Statement.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0"><B>Item 8. Exhibits. </B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0">The following exhibits are filed or incorporated by reference as part
  of this Registration Statement:</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
    <TR>
      <TD STYLE="border-bottom: black 1.5pt solid; vertical-align: top; width: 9%; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Exhibit
      No.</B></FONT></TD>
      <TD STYLE="vertical-align: top; width: 1%">&nbsp;</TD>
      <TD STYLE="text-align: left; border-bottom: black 1.5pt solid; vertical-align: bottom; width: 90%; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Description</B></FONT></TD></TR>
    <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
      <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">4.1</FONT></TD>
      <TD>&nbsp;</TD>
      <TD STYLE="font-size: 10pt; text-align: left"><A HREF="https://www.sec.gov/Archives/edgar/data/1739174/000121390022070435/f10q0922ex3-1_biomxinc.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Composite Copy of the Amended and Restated Certificate of Incorporation of BiomX Inc., as amended to date (Incorporated by reference to the Exhibit 3.1 of BiomX Inc.&rsquo;s Quarterly Report on Form 10-Q filed with the Commission on November 9, 2022).</FONT></A></TD></TR>
    <TR STYLE="vertical-align: top; background-color: White">
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="text-align: left">&nbsp;</TD></TR>
    <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
      <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">4.2</FONT></TD>
      <TD>&nbsp;</TD>
      <TD STYLE="font-size: 10pt; text-align: left"><A HREF="https://www.sec.gov/Archives/edgar/data/1739174/000121390019021849/f8k1019ex3-3_biomx.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Amended and Restated Bylaws of BiomX Inc. (incorporated by reference to Exhibit 3.3 of BiomX Inc.&rsquo;s Current Report on Form 8-K filed with the Commission on November 1, 2019).</FONT></A></TD></TR>
    <TR STYLE="vertical-align: top; background-color: White">
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="text-align: left">&nbsp;</TD></TR>
    <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
      <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">5.1*</FONT></TD>
      <TD>&nbsp;</TD>
      <TD STYLE="font-size: 10pt; text-align: left"><A HREF="ea176021ex5-1_biomxinc.htm"><FONT STYLE="font-size: 10pt">Opinion of Sullivan &amp; Worcester LLP</FONT></A></TD></TR>
    <TR STYLE="vertical-align: top; background-color: White">
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="text-align: left">&nbsp;</TD></TR>
    <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
      <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">23.1*</FONT></TD>
      <TD>&nbsp;</TD>
      <TD STYLE="font-size: 10pt; text-align: left"><A HREF="ea176021ex23-1_biomxinc.htm"><FONT STYLE="font-size: 10pt">Consent of Kesselman &amp; Kesselman, Certified Public Accountants (Isr.), a member firm of PricewaterhouseCoopers International Limited.</FONT></A></TD></TR>
    <TR STYLE="vertical-align: top; background-color: White">
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="text-align: left">&nbsp;</TD></TR>
    <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
      <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">24.1*</FONT></TD>
      <TD>&nbsp;</TD>
      <TD STYLE="font-size: 10pt; text-align: left"><A HREF="#a_001"><FONT STYLE="font-size: 10pt">Power of Attorney (included on the signature pages to this Registration Statement)</FONT></A></TD></TR>
    <TR STYLE="vertical-align: top; background-color: White">
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="text-align: left">&nbsp;</TD></TR>
    <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
      <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">99.1</FONT></TD>
      <TD>&nbsp;</TD>
      <TD STYLE="font-size: 10pt; text-align: left"><A HREF="https://www.sec.gov/Archives/edgar/data/1739174/000121390019021849/f8k1019ex10-10_biomx.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Chardan Healthcare Acquisition Corp. 2019 Omnibus Long-Term Incentive Plan (incorporated by reference to Exhibit 10.10 of the BiomX Inc.&rsquo;s Current Report on Form 8-K filed with the Commission on November 1, 2019)</FONT></A></TD></TR>
    <TR STYLE="vertical-align: top; background-color: White">
      <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
    <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
      <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">107*</FONT></TD>
      <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD>
      <TD STYLE="font-size: 10pt; text-align: left"><A HREF="ea176021ex-fee_biomxinc.htm"><FONT STYLE="font-size: 10pt">Filing Fee Table</FONT></A></TD></TR>
    </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
    <TR STYLE="vertical-align: top">
      <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-size: 10pt">*</FONT></TD>
      <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Filed herewith.</FONT></TD></TR>
    </TABLE>
  
  
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center"></P>
  
  <!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
      <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
      <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center"><B>&nbsp;</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center"><B>SIGNATURES</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0">Pursuant to the requirements of the Securities Act, the registrant
  certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this
  Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Ness Ziona, Israel, on this 29th day
  of March, 2023.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
    <TR STYLE="vertical-align: top">
      <TD>&nbsp;</TD>
      <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">BIOMX INC.</FONT></TD></TR>
    <TR STYLE="vertical-align: top">
      <TD STYLE="width: 60%">&nbsp;</TD>
      <TD STYLE="width: 3%">&nbsp;</TD>
      <TD STYLE="width: 37%">&nbsp;</TD></TR>
    <TR STYLE="vertical-align: top">
      <TD>&nbsp;</TD>
      <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">By</FONT></TD>
      <TD STYLE="border-bottom: black 1.5pt solid; font-size: 10pt"><FONT STYLE="font-size: 10pt">/s/ Jonathan Solomon</FONT></TD></TR>
    <TR STYLE="vertical-align: top">
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Jonathan Solomon</FONT></TD></TR>
    <TR STYLE="vertical-align: top">
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
    </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center"><B>&nbsp;</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center"><A NAME="a_001"></A><B>POWER OF ATTORNEY</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0">KNOW ALL PERSONS BY THESE PRESENTS, that each of the undersigned constitutes
  and appoints each of Mr. Jonathan Solomon and Ms. Marina Wolfson, and each or any one of them, as the undersigned&rsquo;s true and lawful
  attorneys-in-fact and agents, with full powers of substitution and resubstitution, for the undersigned and in the undersigned&rsquo;s
  name, place and stead, in any and all capacities, to sign any and all amendments (including pre-effective and post-effective amendments)
  to this Registration Statement and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities
  and Exchange Commission, granting unto such attorneys-in-fact and agents, full power and authority to do and perform each and every act
  and thing requisite or necessary to be done in and about the premises, as fully to all intents and purposes as the undersigned might or
  could do in person, hereby ratifying and confirming all that such attorneys-in-fact and agents, or their substitute or substitutes, may
  lawfully do or cause to be done by virtue hereof.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0">Pursuant to the requirements of the Securities Act, this Registration
  Statement has been signed below by the following persons in the capacities and on the date indicated.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
    <TR STYLE="vertical-align: top">
      <TD STYLE="border-bottom: black 1.5pt solid; width: 30%; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Signature</B></FONT></TD>
      <TD STYLE="width: 2%">&nbsp;</TD>
      <TD STYLE="border-bottom: black 1.5pt solid; width: 48%; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Title</B></FONT></TD>
      <TD STYLE="width: 2%">&nbsp;</TD>
      <TD STYLE="border-bottom: black 1.5pt solid; width: 18%; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Date</B></FONT></TD></TR>
    <TR STYLE="vertical-align: top">
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="text-align: center">&nbsp;</TD></TR>
    <TR>
      <TD STYLE="border-bottom: black 1.5pt solid; vertical-align: top">
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0">/s/ Russell Greig</P></TD>
      <TD STYLE="vertical-align: top">&nbsp;</TD>
      <TD STYLE="vertical-align: bottom; font-size: 10pt"><FONT STYLE="font-size: 10pt">Chairman of the Board of Directors</FONT></TD>
      <TD STYLE="vertical-align: top">&nbsp;</TD>
      <TD STYLE="text-align: center; vertical-align: bottom; font-size: 10pt"><FONT STYLE="font-size: 10pt">March 28, 2023</FONT></TD></TR>
    <TR STYLE="vertical-align: top">
      <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Dr. Russell Greig</FONT></TD>
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="text-align: center">&nbsp;</TD></TR>
    <TR STYLE="vertical-align: top">
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="text-align: center">&nbsp;</TD></TR>
    <TR>
      <TD STYLE="border-bottom: black 1.5pt solid; vertical-align: bottom; font-size: 10pt"><FONT STYLE="font-size: 10pt">/s/ Jonathan Solomon</FONT></TD>
      <TD STYLE="vertical-align: top">&nbsp;</TD>
      <TD STYLE="vertical-align: top">
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0">Chief Executive Officer</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0"></P></TD>
      <TD STYLE="vertical-align: top">&nbsp;</TD>
      <TD STYLE="text-align: center; vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">March 28, 2023</FONT></TD></TR>
    <TR STYLE="vertical-align: top">
      <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Jonathan Solomon </FONT></TD>
      <TD>&nbsp;</TD>
      <TD>(Principal Executive Officer) and Director</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="text-align: center">&nbsp;</TD></TR>
    <TR STYLE="vertical-align: top">
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="text-align: center">&nbsp;</TD></TR>
    <TR>
      <TD STYLE="border-bottom: black 1.5pt solid; vertical-align: bottom; font-size: 10pt"><FONT STYLE="font-size: 10pt">/s/ Marina Wolfson</FONT></TD>
      <TD STYLE="vertical-align: top">&nbsp;</TD>
      <TD STYLE="vertical-align: top">
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0">Chief Financial Officer</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0"></P></TD>
      <TD STYLE="vertical-align: top">&nbsp;</TD>
      <TD STYLE="text-align: center; vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">March 28, 2023</FONT></TD></TR>
    <TR STYLE="vertical-align: top">
      <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Marina Wolfson</FONT></TD>
      <TD>&nbsp;</TD>
      <TD>(Principal Financial Officer and Principal Accounting Officer)</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="text-align: center">&nbsp;</TD></TR>
    <TR STYLE="vertical-align: top">
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="text-align: center">&nbsp;</TD></TR>
    <TR STYLE="vertical-align: top">
      <TD STYLE="border-bottom: black 1.5pt solid; font-size: 10pt"><FONT STYLE="font-size: 10pt">/s/ Alan Moses</FONT></TD>
      <TD>&nbsp;</TD>
      <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
      <TD>&nbsp;</TD>
      <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-size: 10pt">March 28, 2023</FONT></TD></TR>
    <TR STYLE="vertical-align: top">
      <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Dr. Alan Moses</FONT></TD>
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="text-align: center">&nbsp;</TD></TR>
    <TR STYLE="vertical-align: top">
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="text-align: center">&nbsp;</TD></TR>
    <TR STYLE="vertical-align: top">
      <TD STYLE="border-bottom: black 1.5pt solid; font-size: 10pt"><FONT STYLE="font-size: 10pt">/s/ Lynne Sullivan</FONT></TD>
      <TD>&nbsp;</TD>
      <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
      <TD>&nbsp;</TD>
      <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-size: 10pt">March 28, 2023</FONT></TD></TR>
    <TR STYLE="vertical-align: top">
      <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Lynne Sullivan</FONT></TD>
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="text-align: center">&nbsp;</TD></TR>
    </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: right"><B>&nbsp;</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0"><B>&nbsp;</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0"><B>&nbsp;</B></P>
  
  <P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in">II-2</P>
  
  <!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0"><B></B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: right"><B></B></P>
  
  </BODY>
  </HTML>
metadata_documents: [{"type": "S-8", "sequence": "1", "filename": "ea176021-s8_biomxinc.htm", "description": "REGISTRATION STATEMENT", "secsgml_size_bytes": 37108}]
metadata_filer: {"company-data": {"conformed-name": "BiomX Inc.", "cik": "0001739174", "assigned-sic": "2836", "irs-number": "000000000", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-270947", "film-number": "23776002"}, "business-address": {"street1": "22 EINSTEIN ST., 4TH FLOOR", "city": "NESS ZIONA", "state": "L3", "zip": "7414003", "phone": "(972) 72 394 2377"}, "mail-address": {"street1": "22 EINSTEIN ST., 4TH FLOOR", "city": "NESS ZIONA", "state": "L3", "zip": "7414003"}, "former-company": {"former-conformed-name": "Chardan Healthcare Acquisition Corp.", "date-changed": "20180430"}}
text: As filed with the Securities and Exchange Commission
  on March 29, 2023
  Registration No. 333-
  UNITED STATES
  SECURITIES AND EXCHANGE COMMISSION
  Washington, D.C. 20549
  FORM S-8
  REGISTRATION STATEMENT
  UNDER
  THE SECURITIES ACT OF 1933
  BIOMX INC.
  (Exact Name of Registrant as Specified in its
  Charter)
  Delaware
  2836
  82-3364020
  (State or other jurisdiction of
  incorporation or organization)
  (Primary Standard Industrial
  Classification Code Number)
  (I.R.S. Employer
  Identification No.)
  22 Einstein St., Floor 4
  Ness Ziona, Israel
  +972 723942377
  (Address, including zip code, and telephone
  number, including area code, of Registrant's principal executive offices)
  CHARDAN HEALTHCARE ACQUISITION CORP. 2019 OMNIBUS
  LONG-TERM INCENTIVE PLAN
  (Full title of the plans)
  Marina Wolfson
  BiomX Inc.
  22 Einstein St., Floor 4
  Ness Ziona, Israel
  +972 723942377
  (Name, address, including zip code, and telephone
  number, including area code, of agent for service)
  Copies to:
  Howard E. Berkenblit
  Sullivan & Worcester LLP
  One Post Office Square
  Boston, Massachusetts 02109
  (617) 338-2800
  Indicate by check mark whether the registrant is a large accelerated
  filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated
  filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.
  Large accelerated filer
  ☐
  Accelerated filer
  ☐
  Non-accelerated filer
  ☒
  Smaller reporting company
  ☒
  Emerging growth company
  ☒
  If an emerging growth company, indicate by check mark if the registrant
  has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
  to Section 7(a)(2)(B) of the Securities Act.
  ☒
  EXPLANATORY NOTE
  On January 2, 2020, BiomX Inc., or the Company, filed a Registration
  Statement on Form S-8 (File No. 333-235777), or, as amended, the Original Registration Statement, with the Securities and Exchange Commission,
  or the Commission, to register an aggregate of 1,000 shares of Common Stock of the Company that may be issued pursuant to the Chardan
  Healthcare Acquisition Corp. 2019 Omnibus Long-Term Incentive Plan, or the 2019 Plan, as well as 3,148,360 shares of Common Stock of the
  Company that may be issued pursuant to the 2015 Employee Stock Option Plan for Key Employees of BiomX Ltd., as amended.
  Pursuant to the 2019 Plan, the number of shares of Common Stock of
  the Company made available under the 2019 Plan will automatically increase on January 1 of each year, for a period of not more than ten
  years, commencing on January 1, 2020 and ending on (and including) January 1, 2029, in an amount equal to 4% of the total number of shares
  of Common Stock outstanding on December 31 of the preceding calendar year, or the Evergreen Mechanism.
  In accordance with the Evergreen Mechanism, the number of shares of
  Common Stock of the Company reserved under the 2019 Plan increased by 914,741, 930,813 and 1,190,129 shares of Common Stock effective
  January 1, 2020, January 1, 2021 and January 1, 2022, respectively. Further, in accordance with the Evergreen Mechanism, the number of
  shares of Common Stock of the Company reserved under the 2019 Plan increased by 1,199,291 shares of Common Stock effective January 1,
  2023.
  The Company is filing this Registration Statement on Form S-8 to register
  an additional 1,199,291 shares of Common Stock of the Company, which may be issued in connection with securities awards, which have been
  granted or may hereafter be granted under the 2019 Plan. The 1,199,291 shares of Common Stock of the Company being registered hereunder
  for the 2019 Plan are comprised of: (i) 675,567 shares of Common Stock subject to awards granted on March 1, 2023; and (ii) 523,724 shares
  of Common Stock available for issuance.
  Pursuant to General Instruction E to Form S-8, the contents of the
  Original Registration Statement are incorporated herein by reference, except for Item 3 and Item 8 of Part II of the Original Registration
  Statement, which are being updated by this Registration Statement.
  PART II
  INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
  Item 3. Incorporation of Documents by Reference.
  The following documents filed with the Securities and Exchange Commission,
  or the Commission, by BiomX Inc., or the Registrant, pursuant to the Securities Act of 1933, as amended, and the Securities Exchange Act
  of 1934, as amended, or the Exchange Act, are hereby incorporated by reference in this Registration Statement:
  (a)
  The Registrant's Annual Report on
  Form 10-K
  for the year ended December 31, 2022, filed with the Commission on March 29, 2023;
  (b)
  The Registrant's Current Reports on Form 8-K filed
      on
  January
      6, 2023
  ,
  February 22, 2023
  (Items 1.01, 3.02, 8.01 and exhibits 4.1, 10.1 and 10.2 only),
  February 27, 2023
  , and
  March 29, 2023
  (Item 5.08 only); and
  (c)
  The description of our common stock, warrants and units contained in the Registration Statement on
  Form 8-A
  filed on December 13, 2018, under the Exchange Act, including any amendment or report filed or to be filed for the purpose of updating such description.
  All documents that the Registrant subsequently files pursuant to Sections
  13(a), 13(c), 14 and 15(d) of the Exchange Act after the date of this Registration Statement and prior to the filing of a post-effective
  amendment to this Registration Statement indicating that all securities offered have been sold or which deregisters all securities then
  remaining unsold, shall be deemed to be incorporated by reference into this Registration Statement and to be a part hereof from the date
  of filing of such documents; provided, however, that documents or information deemed to have been furnished and not filed shall not be
  incorporated by reference into this Registration Statement.
  Any statement contained in a document incorporated or deemed to be
  incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent
  that a statement contained herein or in any other subsequently filed document which also is or is deemed to be incorporated by reference
  herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified
  or superseded, to constitute a part of this Registration Statement.
  Item 8. Exhibits.
  The following exhibits are filed or incorporated by reference as part
  of this Registration Statement:
  Exhibit
      No.
  Description
  4.1
  Composite Copy of the Amended and Restated Certificate of Incorporation of BiomX Inc., as amended to date (Incorporated by reference to the Exhibit 3.1 of BiomX Inc.'s Quarterly Report on Form 10-Q filed with the Commission on November 9, 2022).
  4.2
  Amended and Restated Bylaws of BiomX Inc. (incorporated by reference to Exhibit 3.3 of BiomX Inc.'s Current Report on Form 8-K filed with the Commission on November 1, 2019).
  5.1*
  Opinion of Sullivan & Worcester LLP
  23.1*
  Consent of Kesselman & Kesselman, Certified Public Accountants (Isr.), a member firm of PricewaterhouseCoopers International Limited.
  24.1*
  Power of Attorney (included on the signature pages to this Registration Statement)
  99.1
  Chardan Healthcare Acquisition Corp. 2019 Omnibus Long-Term Incentive Plan (incorporated by reference to Exhibit 10.10 of the BiomX Inc.'s Current Report on Form 8-K filed with the Commission on November 1, 2019)
  107*
  Filing Fee Table
  *
  Filed herewith.
  II-
  1
  SIGNATURES
  Pursuant to the requirements of the Securities Act, the registrant
  certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this
  Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Ness Ziona, Israel, on this 29th day
  of March, 2023.
  BIOMX INC.
  By
  /s/ Jonathan Solomon
  Jonathan Solomon
  Chief Executive Officer
  POWER OF ATTORNEY
  KNOW ALL PERSONS BY THESE PRESENTS, that each of the undersigned constitutes
  and appoints each of Mr. Jonathan Solomon and Ms. Marina Wolfson, and each or any one of them, as the undersigned's true and lawful
  attorneys-in-fact and agents, with full powers of substitution and resubstitution, for the undersigned and in the undersigned's
  name, place and stead, in any and all capacities, to sign any and all amendments (including pre-effective and post-effective amendments)
  to this Registration Statement and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities
  and Exchange Commission, granting unto such attorneys-in-fact and agents, full power and authority to do and perform each and every act
  and thing requisite or necessary to be done in and about the premises, as fully to all intents and purposes as the undersigned might or
  could do in person, hereby ratifying and confirming all that such attorneys-in-fact and agents, or their substitute or substitutes, may
  lawfully do or cause to be done by virtue hereof.
  Pursuant to the requirements of the Securities Act, this Registration
  Statement has been signed below by the following persons in the capacities and on the date indicated.
  Signature
  Title
  Date
  /s/ Russell Greig
  Chairman of the Board of Directors
  March 28, 2023
  Dr. Russell Greig
  /s/ Jonathan Solomon
  Chief Executive Officer
  March 28, 2023
  Jonathan Solomon
  (Principal Executive Officer) and Director
  /s/ Marina Wolfson
  Chief Financial Officer
  March 28, 2023
  Marina Wolfson
  (Principal Financial Officer and Principal Accounting Officer)
  /s/ Alan Moses
  Director
  March 28, 2023
  Dr. Alan Moses
  /s/ Lynne Sullivan
  Director
  March 28, 2023
  Lynne Sullivan
  II-2